It was found a significant decrease in the frequency of Ki-67 positive tumor cells at surgery after 5 cycles of 4-week combinational therapy (40.4% vs. 17.9%, baseline vs. surgery; P < 0.001), suggesting the antiproliferative effect of the triple-combination regimen in this population. The gene discussed is MKI67; the disease is neoplasm.